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Simon-Djamel Thiberville1,2*, Jean Gaudart3, Didier Raoult2 and Remi N. Charrel1,2Abstract
Background: Following the 2009 influenza pandemic, several studies showed that the mortality pattern associated
with the A(H1N1)2009 virus primarily affected children and young adults. In this study, we aimed to estimate the
influenza-attributable deaths during the periods from 1999 to 2010, in the Provence-Alpes-Côte-d’Azur (PACA)
region of south-eastern France in order to corroborate the hypothesis that (i) influenza-attributable deaths
caused by A(H1N1)2009 strain were much lower than initially expected.
Methods: In order to compare our results with published data, we used the same statistical model of an Austrian
team, using a Poisson model adjusted on co-circulating respiratory syncytial virus to explain the weekly mortality.
Results: We assessed that 5.7 % of the respiratory deaths were attributable to influenza virus during the 2009–2010
pandemic season. This mortality was lower than that observed during the ten preceding epidemic periods (13.8 % on
average). Age group- based analysis revealed that during the pandemic period, the groups under 65 had a
systematically higher excess of respiratory mortality while the age group over 65 had a much lower mortality
than during the seasonal epidemic seasons. Similarly, among the less specific outcome (non violent and cardiovascular
mortality) the age groups over 45 had higher excess of mortality during the seasonal epidemics than during the
pandemic period.
Conclusions: Since most of the influenza mortality is commonly observed in the elderly group (>65 year-old),
the moderate elderly mortality during the 2009 pandemic period has impacted the total mortality, and has
resulted in a reduced total mortality despite an increased mortality in the young age group. Despite using
identical parameters and the same approach as in a previously published study using an Austrian population
sample, we observed a lower excess respiratory mortality in the south-eastern France than in Vienna. Thus,
the pandemic virus caused less death than the epidemic viruses that circulated during the preceding years. In
contrast with catastrophic predictions made in the early phase of the pandemic, human lives were saved during
the circulation period of A(H1N1)2009 virus, resulting in a lower overall mortality.
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In April 2009, a novel influenza A(H1N1)2009 virus emerged
in Mexico and spread rapidly worldwide leading the
World Health Organization (WHO) to declare the first
influenza pandemic of the twenty-first century [1]. Soon
after, dreadful predictions were made and amplified by
maintained confusion between H5N1 and H1N1 viruses
and vaccine safety issues in scientific and public media
[2–4]. The first studies on the mortality of the new pan-
demic influenza virus showed that children and young
adults were primarily affected [5,6]. In contrast, elderly were
protected due to previous infection with an antigenically-
related influenza virus during youth [7]. Assessing the
number of deaths attributable to influenza epidemics is
difficult because most of deaths occur after the acute phase
of viral infection from bacterial super-infection or from
complications of chronic illnesses. Accordingly, in both
cases the primary viral infection is no longer directly de-
tectable. A commonly accepted approach consists of using
statistical time series seasonal regression models of differ-
ent causes of death recorded by national system [8]. In an
Austrian study, mortality attributable to A(H1N1)2009 in-
fluenza virus adjusted on co-circulating respiratory syncyt-
ial virus (RSV) in the area of Vienna, Austria was lower
during the pandemic than during the preceding epidemic
periods (1999/2000–2008/2009). Attributable mortality in-
creased significantly for the age groups below 34 years old
and decreased significantly for those above 55 during the
pandemic compared to the epidemics periods [9].
Using the same approach, we estimated the seasonal
influenza-attributable deaths from 1999 to 2009, and the
pandemic influenza-attributable deaths in 2010, in the
Provence-Alpes-Côte-d’Azur (PACA) region of south-eastern
France in order to corroborate the hypothesis that (i)
influenza-attributable deaths caused by A(H1N1)2009
strain were much lower than initially expected, (ii)
and that A(H1N1)2009 virus primarily affected young
people [10].
Methods
Mortality data and study population
We used the weekly reported deaths of the PACA region
south-eastern France, from week 52, 1999 through week 51,
2010 collected by INSERM CépiDc [11]. The file contained
gender, age at death grouped in 5 year ranges, week of
death, and cause of death using the four digit International
Classification of Diseases (ICD) code (10th revision).
Population of PACA was 4.5 millions in 1999 and 4.9
millions in 2010 according to the French National Institute
of Statistics and Economic Studies [7].
Surveillance of Influenza virus infections
Influenza activity is mainly monitored in France through
the sentinel practitioner network [12] that records theweekly number of influenza-like illness (ILI) syndrome,
defined as sudden abrupt onset fever above 39 °C AND
respiratory signs AND myalgia [13].
The onset of the influenza epidemic period was defined
as the first week with ILI count (per 100,000 inhabitants)
above the threshold value.
The end of the influenza epidemic period was defined
as the last week with ILI count (per 100,000 inhabitants)
below the threshold value.
The threshold was defined from non-epidemic baseline
of ILI count, forecasted by the sentinel networks [13].
The most prevalent type and subtype of influenza viruses
that circulated each year were defined by the national ref-
erence centre for influenza [5].
Respiratory syncytial virus (RSV) surveillance
Nasopharyngeal aspirates (NPA) or nasal swabs (NS) were
obtained from patients admitted to the Public Hospital
of Marseille, France, who were clinically suspect for
RSV. Direct detection of RSV was performed by real-time
RT-PCR as described previously [14].
Statistical analysis
In order to compare our results with published data, we
used the same statistical model used by Redlsperger-Fritz
[9]. General linear models (glm) were used to estimate the
expected number of deaths according to a Poisson distri-
bution model. The population log was used as an offset.
Cofactors were the total number of RSV, the epidemic
weeks (dummy variable), and the sinusoidal transform-
ation of time. The attributable number of deaths ADj for
epidemic weeks j were estimated as following:
ADj ¼ Dj 1− exp −θj
  
Where, for the epidemic week j, D was the number of
deaths and θ the associated parameter estimated by the
glm. The dependent variables were the weekly deaths from
all non-violent causes (all codes except ICD9: 800–999,
ICD10: S/T), from respiratory diseases (ICD9: 460–519,
ICD10: J), and from cardiovascular diseases (ICD9: 390–
459, ICD10: I). To assess the excess mortality by age group,
we used 4 age groups (0–24, 25–44, 45–64 and > 65 year-
old).
All statistics were provided by using the R software
(version R3.1.0; http://www.r-project.org/).
Results
During the studied period, 470,957 non violent deaths
were registered, including 31,688 respiratory- and 142,352
cardiovascular- related deaths.
A total of 1,862,815 ILI were recorded during the eleven
influenza waves (ten epidemic seasons and one pandemic
season), and 443,376 ILI were recorded during the non-
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recorded per epidemic/pandemic season (range 81,425–
266,313). The mean number of epidemic/pandemic weeks
per year was ten, ranging from 7 (2006/2007) to 19 (2009/
2010).
According to the National Reference Centre of Influenza,
6/10 epidemic seasons witnessed circulation of A/H3N2
virus subtype, whereas A/H1N1 virus subtype and B virus
type co-circulated during the 4 remaining epidemic sea-
sons. During the pandemic period virus circulation was
due almost exclusively to A(H1N1)2009 influenza.
A total of 24,329 samples were tested for RSV in the vir-
ology laboratory, of which 3,676 (15.1 %) were positive for
RSV RNA. The mean yearly number of RSV-positive sam-
ples was 333 (range 81–565).
We estimated the excess of mortality (non violent, re-
spiratory, and cardiovascular) during the influenza epi-
demic periods in the population of the studied region,
and during each epidemic year (from 1999–2000 to 2009–
2010) (Table 1).
During the ten influenza epidemic seasons, the excess
respiratory mortality ranged from 1.35 to 2.91 per 100,000
inhabitants corresponding to an average 13.8 % of the re-
spiratory deaths (12.7–15.2 %). An excess of respiratory
mortality could be attributable to the influenza subtype
with an average mortality of 2.21 and 1.71 per 100,000
for the A/H3N2 subtype seasons on the one hand and
A/H1N1-B subtypes seasons on the other hand, respect-
ively. In contrast, during the 2009 pandemic season, a
non-significant excess of respiratory deaths (55; 95 %
CI[−115;206]) was attributable to the A(H1N1)2009
pandemic period corresponding to an excess respira-
tory mortality of 1.12 per 100,000 (5.7 % of the respira-
tory deaths).
Among the less specific outcome, the excess mortality
during the epidemic seasons ranged from 3.02 to 6.48Table 1 Excess mortality (per 100,000 inhabitants) attributable to inf
Provence-Alpes-Côte-d’Azur (PACA) region, France
Epidemic season
of influenza
Non violent mortality
N [CI] (per 100,000)
1999/2000 198 [106;370] (4.36)
2000/2001 184 [77;365] (4.01)
2001/2002 190 [71;388] (4.10)
2002/2003 291 [83;633] (6.22)
2003/2004 195 [88;370] (4.13)
2004/2005 275 [109;563] (5.77)
2005/2006 171 [67;344] (3.55)
2006/2007 147 [54;310] (3.02)
2007/2008 173 [63;355] (3.54)
2008/2009 317 [141;624] (6.48)
2009/2010 274 [−324;996] (5.59)and from 0.84 to 1.26 per 100,000 for the non violent
and cardiovascular mortality respectively. During the pan-
demic period, the excess of non violent mortality was
similar to the excess of non violent mortality during epi-
demic periods (5.59 per 100,000), but this excess was not
significant. Furthermore, a non significant negative excess
of mortality (−2.31 per 100,000) was estimated for cardio-
vascular mortality.
Age group- based analysis (Fig. 1) revealed an excess
respiratory mortality during seasonal epidemic seasons
with the following ranges: −0.14 - 0.07, −0.16 - 0.16, 0.16 -
0.46, and 6.27 - 13.23 per 100,000 observed in the respect-
ive age groups 0–24, 25–44, 45–64 and > 65 year-old. In
contrast during the pandemic period, the groups under 65
had a systematically higher excess of respiratory mortality
(0.28, 0.58 and 0.62 for the age groups 0–24, 25–44 and
45–64 respectively) while the age group over 65 had a
much lower mortality (1.14 per 100,000).
For non violent and cardiovascular mortality the age
groups over 45 had higher excess of mortality during the
seasonal epidemics (45–64 years: ranging from −1.46 to
0.18 for non violent mortality and from 0.58 to 0.81 for
cardiovascular mortality; over 65: ranging from 15.10 to
26.14 for non violent mortality and from 2.40 to 5.86 for
cardiovascular mortality) than during the pandemic period
(45–64 years: −3.77 for non violent mortality and −0.69
for cardiovascular mortality; over 65: 2.91 for non violent
mortality and −19.03 for cardiovascular mortality).
Discussion
We assessed that respiratory mortality attributable to in-
fluenza was lower during the pandemic period than dur-
ing the epidemic seasons. Since most of the influenza
mortality is commonly observed in the elderly group
(>65 year-old), the moderate elderly mortality during the
2009 pandemic period has impacted the total mortality,luenza virus per season from 1999/2000 to 2009/2010 in the
Respiratory mortality
N [CI] (per 100,000)
Cardiovascular mortality
N [CI] (per 100,000)
116 [81;171] (2.55) 57 [−4;150] (1.26)
77 [49;117] (1.68) 54 [−16;153] (1.18)
93 [57;145] (2.01) 54 [−23;165] (1.17)
109 [54;182] (2.33) 50 [−81;248] (1.07)
94 [61;139] (1.99) 52 [−13;146] (1.10)
139 [82;221] (2.91) 58 [−44;215] (1.22)
65 [40;99] (1.35) 48 [−17;139] (1.00)
79 [52;119] (1.62) 41 [−16;124] (0.84)
73 [43;116] (1.50) 48 [−19;142] (0.98)
107 [54;180] (2.19) 56 [−45;219] (1.15)
55 [−115;206] (1.12) −113 [−460;266] (−2.31)
Fig. 1 Excess influenza respiratory mortality (per 100,000 inhabitants) by group of age (0–24 in blue, 25–44 in red, 45–64 in green and over
65 years old in purple) estimated during the 2009 pandemic and the ten preceding epidemics in the Provence-Alpes-Côte-d’Azur (PACA) region,
France. The method use to assess the mortality attributable to influenza virus was previously described [9]
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increased mortality in the young age group.
Similarly, in Austria, Redlsperger-Fritz et al. reported
an excess mortality in the young age groups (<34 year-
old) and a reduced mortality in age groups > 55 year-old
during the 2009 pandemic period, compared with the epi-
demic seasons [9]. In France, Lemaitre et al. showed that
the mortality burden of the 2009 pandemic was particu-
larly mild except in the age groups 5 to 44 years old [5].
The reasons for this low mortality among elderly may
relate to the existence of prior immunity of individuals
born before 1957 after infection with an A(H1N1)2009
antigenically related virus [15,16]. The specific age-related
2009 pandemic mortality pattern which was also noticed
in previous influenza pandemics (1957, 1968) is currently
considered as a signature of the influenza pandemics [5].
Since cardio-vascular diseases are reduced by the influ-
enza vaccination in elderly patients [17], we considered it
interesting to analyse the excess cardiovascular mortality
attributable to influenza. Interestingly, as showed for the
respiratory mortality, the excess cardiovascular mortality
during the epidemic seasons was higher than during thepandemic period during which a non significant negative
excess of mortality was observed. Pre-existing exposure to
closely related viruses prior to 1957 may have provided
cross-reactive immunity during the A(H1N1)2009 out-
break in the same way influenza vaccination may reduce
the incidence of influenza-related complications [17].
In our study, the mortality was dependent on the pre-
dominant influenza subtype circulating: A/H3N2 was asso-
ciated with higher mortality than A/H1N1 and B influenza
virus. The same trend was identified in the Austrian study
[9]. A higher mortality was also observed in all age
groups with the A(H3N2)1968 pandemic compared to
the A(H1N1)2009 pandemic [5].
Although most countries reported a lower impact on the
overall mortality during the 2009 pandemic compared to
the previous seasonal mortality, the number of excess
deaths attributable to influenza was highly variable in the
literature [5,6]. Despite using identical parameters such as
respiratory mortality and the same age classes, great varia-
tions were observed in excess mortality from 4.1 per
100,000 in France to 10.5 per 100,000 in Mexico during the
2009 pandemic [5,6]. Whether some of these differences
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prior immunity, health care, climate variations, co-
circulation of other viruses or was due to the use of differ-
ent statistical models remains to be clarified.
Here, we used an approach identical to that used by
Redlsperger-Fritz et al. in Austria, incorporating RSV
circulation as a covariate [9]. However, in the elderly age
group we observed a lower excess respiratory mortality
in south-eastern France than in Vienna (1.12 vs 10.8 per
100,000 inhabitants during the A(H1N1)2009 pandemic
[9]. Moreover, as Lemaitre et al. previously reported, we
also found a negative attributable mortality during the
pandemic period for the less specific outcome in the
analysis by age group [5]. This may be due to the par-
ticularly mild mortality impact of the pandemic 2009 in
France, which, with regards to non specific mortality,
was overflowed by the mortality attributable to other
cause [11].
The mortality attributable to the influenza epidemics
has been the subject of numerous front line articles but
none could forecast that the most recent influenza pan-
demic had been associated with a very low mortality im-
pact [18] whereas during the same period the influenza
vaccination coverage was historically low in the general
population in France [19]. Immune protection due to past
exposure to antigenetically related viruses is important
when estimating/modeling the disease impact of a new
viral threat. The A(H1N1)2009 pandemic could have had
serious consequences, had the age group of the elderly
not been partially immune to the virus. Using an effect-
ive vaccine in the children on the other hand, could have
major impact on preventing spread of pandemic viruses –
including to other risk groups, such as the elderly, as pre-
viously demonstrated [20].
Conclusion
Compared to previous seasonal influenza epidemics, the
2009 influenza pandemic has resulted in a reduction of the
total mortality, due to a reduced death rate in the elderly
population; the introduction of the novel A(H1N1)2009
pandemic virus has saved lives.Competing interests
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